We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
First published during the 2019 to 2022 Johnson Conservative government
Example of a completed new project licence application - tumour Date: Tue Nov 03 12:19:17 GMT 2009 Full Document Example of a completed…
AGIR's ninth report (RCE-19): covers the risk of ionising radiation on the development of solid cancers but excludes leukaemia and lymphoma.
COMARE’s 14th report: review of the risk of childhood cancer near UK nuclear power plants from 1969 to 2004.
Volume 42 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Volume 46 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
First published during the 2022 to 2024 Sunak Conservative government
Volume 43 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
This is a review of entitlement to Industrial Injuries Disablement Benefit for people with terminal cancer.
Employment Tribunal decision.
Findings from research by the MHRA have been published, evaluating two different approaches to cancer therapies which harness the immune system to determine which better targets cancer cells and would reduce side effects for patients.
Cases of severe cutaneous adverse reactions, including Stevens-Johnsons syndrome (SJS) and toxic epidermal necrolysis (TEN), have been reported in patients treated with immune-stimulatory anti-cancer drugs, including atezolizumab. Advise patients to be vigilant for the signs of severe skin reactions and...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).